N

North Carolina Clinical Research | Raleigh, NC

Research site

(Unclaimed)

Location

2615 Lake Drive, Suite 301, Raleigh, North Carolina, United States of America

Site insights

Top conditions

Top treatments

azelastine hydrochloride

fluticasone propionate

SUN-101

azelastine Hcl

azelastineHcl

Ciclesonide Hydrofluoroalkane

RN316

Olodaterol

HFA

PF-04950615

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 60 total trials

A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

This is a US study comparing the efficacy and safety of BDA MDI \[Budesonide/Albuterol Sulfate (BDA) metered dose inhaler (MDI)\] with AS \[Albuterol...

Active, not recruiting

Asthma

Drug: BDA MDI

Drug: AS MDI

A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)

This study is to evaluate the Pharmacodynamic (PD), safety, tolerability, Pharmacokinetic (PK), and plasma biomarker response of KAN-101 in participa...

Enrolling

Celiac Disease

Drug: Cohort 2 in Part A

Drug: Group 4 in Part B and Part C

Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients

This study is to characterize the safety and tolerability of an investigational drug called DONQ52 and consists of a single ascending dose part (Part...

Active, not recruiting

Celiac Disease

Drug: Placebo

Drug: DONQ52